News & Events
-
September 6, 2018
Literature review to characterize the empirical basis for response scale selection in pediatric populations
Naegeli AN, Hanlon J, Gries KS, Safikhani S, Ryden A, Patel M, et al. Literature review to characterize the empirical basis for response scale selection in pediatric populations. Journal of Patient-Reported Outcomes. 2018;2:39.
-
September 1, 2018
Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis
Rancoita PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, Hoosdally SJ, Walker TM, et al. Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2018 Sep;62(9).
-
September 1, 2018
Training on the use of technology to collect patient-reported outcome data electronically in clinical trials: best practice recommendations from the ePRO Consortium
Ly, JJ, Crescioni, M, Eremenco, S, Bodart, S, Donoso, M, Butler, AJ, et al. Training on the use of technology to collect patient-reported outcome data electronically in clinical trials: best practice recommendations from the ePRO Consortium. Therapeutic Innovation & Regulatory Science. 2018;1–10. -
August 10, 2018
CPAD Has Two Posters Accepted to Alzheimer’s Association International Conference
The Alzheimer’s Association International Conference (AAIC) is the largest annual scientific meeting with focus on Alzheimer disease (AD). More than 6,500 researchers and participants from pharma, academia, patent-advocacy organizations and other groups came together in Chicago between July 22nd and 26th to exchange the latest developments and research results. Each year, on behalf of our... -
August 10, 2018
Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment
The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public workshop titled “Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment. This public workshop is planned and presented in collaboration with the Transplant Therapeutics Consortium (TTC), a public-private partnership between the FDA, transplantation...